Quick Answer
HARVARD BIOSCIENCE INC reported Cash and Equivalents of $8.61 million for fiscal year 2025.
HARVARD BIOSCIENCE INC Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $8.61M | +109.7% |
| 2024 | $4.11M | -4.1% |
| 2023 | $4.28M | -5.0% |
| 2022 | $4.51M | -42.4% |
| 2021 | $7.82M | -6.0% |
| 2020 | $8.32M | -0.2% |
| 2019 | $8.34M | +2.0% |
| 2018 | $8.17M | +57.4% |
| 2017 | $5.19M | -7.2% |
| 2016 | $5.60M | -17.0% |
| 2015 | $6.74M | -52.3% |
| 2014 | $14.13M | -45.2% |
| 2013 | $25.77M | +24.6% |
| 2012 | $20.68M | +15.4% |
| 2011 | $17.92M | -9.1% |
| 2010 | $19.70M | +18.8% |
| 2009 | $16.59M | +21.1% |
| 2008 | $13.70M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $6.82M | +49.2% | -8.4% |
| June 30, 2025 | $7.44M | +83.8% | +34.2% |
| March 31, 2025 | $5.55M | +30.3% | +35.0% |
| December 31, 2024 | $4.11M | -4.1% | -10.1% |
| September 30, 2024 | $4.57M | -14.4% | +12.9% |
| June 30, 2024 | $4.05M | -6.4% | -4.9% |
| March 31, 2024 | $4.25M | +12.3% | -0.7% |
| December 31, 2023 | $4.28M | -5.0% | -19.8% |
- HARVARD BIOSCIENCE INC showed an increase of +109.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2008–2025 period, HARVARD BIOSCIENCE INC’s cash and equivalents has declined by 37.1% (from $13.70 million to $8.61 million).
- The most recent figure is from HARVARD BIOSCIENCE INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: